These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


965 related items for PubMed ID: 9824158

  • 1. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD, Bardwell VJ.
    Oncogene; 1998 Nov 12; 17(19):2473-84. PubMed ID: 9824158
    [Abstract] [Full Text] [Related]

  • 2. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S, Guerardel C, Leprince D.
    Proc Natl Acad Sci U S A; 1999 Dec 21; 96(26):14831-6. PubMed ID: 10611298
    [Abstract] [Full Text] [Related]

  • 3. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
    Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O.
    Nucleic Acids Res; 1998 Oct 15; 26(20):4645-51. PubMed ID: 9753732
    [Abstract] [Full Text] [Related]

  • 4. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
    Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V, Prive GG, Licht JD.
    Mol Cell Biol; 2002 Mar 15; 22(6):1804-18. PubMed ID: 11865059
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional repression by the proto-oncogene BCL-6.
    Seyfert VL, Allman D, He Y, Staudt LM.
    Oncogene; 1996 Jun 06; 12(11):2331-42. PubMed ID: 8649773
    [Abstract] [Full Text] [Related]

  • 6. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
    Dhordain P, Albagli O, Lin RJ, Ansieau S, Quief S, Leutz A, Kerckaert JP, Evans RM, Leprince D.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10762-7. PubMed ID: 9380707
    [Abstract] [Full Text] [Related]

  • 7. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D.
    Cell Growth Differ; 1995 Dec 30; 6(12):1495-503. PubMed ID: 9019154
    [Abstract] [Full Text] [Related]

  • 8. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H, Leo C, Schroen DJ, Chen JD.
    Mol Endocrinol; 1997 Dec 30; 11(13):2025-37. PubMed ID: 9415406
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
    Ahmad KF, Melnick A, Lax S, Bouchard D, Liu J, Kiang CL, Mayer S, Takahashi S, Licht JD, Privé GG.
    Mol Cell; 2003 Dec 30; 12(6):1551-64. PubMed ID: 14690607
    [Abstract] [Full Text] [Related]

  • 10. BCoR, a novel corepressor involved in BCL-6 repression.
    Huynh KD, Fischle W, Verdin E, Bardwell VJ.
    Genes Dev; 2000 Jul 15; 14(14):1810-23. PubMed ID: 10898795
    [Abstract] [Full Text] [Related]

  • 11. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
    Lausen J, Cho S, Liu S, Werner MH.
    J Biol Chem; 2004 Nov 19; 279(47):49281-8. PubMed ID: 15377655
    [Abstract] [Full Text] [Related]

  • 12. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
    Choi KC, Oh SY, Kang HB, Lee YH, Haam S, Kim HI, Kim K, Ahn YH, Kim KS, Yoon HG.
    Biochem J; 2008 Apr 01; 411(1):19-26. PubMed ID: 18052923
    [Abstract] [Full Text] [Related]

  • 13. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
    Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morriss-Kay G, Zelent A.
    Oncogene; 1999 Jan 14; 18(2):365-75. PubMed ID: 9927193
    [Abstract] [Full Text] [Related]

  • 14. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
    Loinder K, Söderström M.
    J Steroid Biochem Mol Biol; 2004 Aug 14; 91(4-5):191-6. PubMed ID: 15336696
    [Abstract] [Full Text] [Related]

  • 15. Oligomerization of ETO is obligatory for corepressor interaction.
    Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, Maccarana M, Minucci S, Pelicci PG, Lazar MA.
    Mol Cell Biol; 2001 Jan 14; 21(1):156-63. PubMed ID: 11113190
    [Abstract] [Full Text] [Related]

  • 16. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H, Nawaz Z, Tsai SY, O'Malley BW, Tsai MJ.
    Mol Endocrinol; 1997 Jun 14; 11(6):714-24. PubMed ID: 9171235
    [Abstract] [Full Text] [Related]

  • 17. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN.
    Mol Endocrinol; 2001 Jul 14; 15(7):1049-61. PubMed ID: 11435607
    [Abstract] [Full Text] [Related]

  • 18. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P, Albagli O, Honore N, Guidez F, Lantoine D, Schmid M, The HD, Zelent A, Koken MH.
    Oncogene; 2000 Dec 14; 19(54):6240-50. PubMed ID: 11175338
    [Abstract] [Full Text] [Related]

  • 19. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor.
    Lutz M, Baniahmad A, Renkawitz R.
    Biochem Soc Trans; 2000 Dec 14; 28(4):386-9. PubMed ID: 10961925
    [Abstract] [Full Text] [Related]

  • 20. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
    Zhang XM, Chang Q, Zeng L, Gu J, Brown S, Basch RS.
    BMC Cell Biol; 2006 Aug 07; 7():31. PubMed ID: 16893456
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.